Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing

Overview

Journal Cancer Res

Specialty Oncology

Date 2009 May 28

PMID 19470765

Citations 38

Authors

Minakshi Guha

Janet Plescia

Irwin Leav

Jing Li

Lucia R Languino

Dario C Altieri

Affiliations

Soon will be listed here.

Abstract

Endogenous tumor suppression provides a barrier against oncogenesis, but the molecular requirements of this process are not well understood. Here, we show that the dual specificity phosphatase PTEN, a gene almost universally altered in human tumors, silences the expression of survivin, an essential regulator of cell division and apoptosis in cancer. This pathway is independent of p53, involves active repression of survivin gene transcription, and is mediated by direct occupancy of the survivin promoter by FOXO1 and FOXO3a factors. Conditional deletion of PTEN in the mouse prostate causes deregulated induction of survivin before full-blown transformation in vivo, whereas expression of survivin and PTEN is inversely correlated in cancer patients. Therefore, silencing the survivin gene is an essential requirement of endogenous PTEN tumor suppression.

Citing Articles

Prognostic and clinicopathological significance of survivin in gynecological cancer.

Chuwa A, Mvunta D Oncol Rev. 2024; 18:1444008.

PMID: 39687493 PMC: 11646728. DOI: 10.3389/or.2024.1444008.

Survivin as a Therapeutic Target for the Treatment of Human Cancer.

Wang Q, Greene M Cancers (Basel). 2024; 16(9).

PMID: 38730657 PMC: 11083197. DOI: 10.3390/cancers16091705.

Post-transcriptional regulation of BIRC5/survivin expression and induction of apoptosis in breast cancer cells by tristetraprolin.

Al-Yahya S, Al-Saif M, Al-Ghamdi M, Moghrabi W, Khabar K, Al-Souhibani N RNA Biol. 2023; 21(1):1-15.

PMID: 38111129 PMC: 10761079. DOI: 10.1080/15476286.2023.2286101.

Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin.

Liu J, Zhang Q, Wang C, Yang J, Yang S, Wang T Int J Mol Sci. 2023; 24(8).

PMID: 37108785 PMC: 10142662. DOI: 10.3390/ijms24087622.

Platelets Facilitate Wound Healing by Mitochondrial Transfer and Reducing Oxidative Stress in Endothelial Cells.

Jin P, Pan Q, Lin Y, Dong Y, Zhu J, Liu T Oxid Med Cell Longev. 2023; 2023:2345279.

PMID: 36860732 PMC: 9970712. DOI: 10.1155/2023/2345279.

References

Xia F, Altieri D . Mitosis-independent survivin gene expression in vivo and regulation by p53. Cancer Res. 2006; 66(7):3392-5. DOI: 10.1158/0008-5472.CAN-05-4537. View

Keniry M, Parsons R . The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene. 2008; 27(41):5477-85. DOI: 10.1038/onc.2008.248. View

Shen W, Balajee A, Wang J, Wu H, Eng C, Pandolfi P . Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 2007; 128(1):157-70. DOI: 10.1016/j.cell.2006.11.042. View

Li F, Altieri D . Transcriptional analysis of human survivin gene expression. Biochem J. 1999; 344 Pt 2:305-11. PMC: 1220645. DOI: 10.1042/0264-6021:3440305. View

Altieri D . Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2007; 8(1):61-70. DOI: 10.1038/nrc2293. View

Mirza A, McGuirk M, Hockenberry T, Wu Q, Ashar H, Black S . Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene. 2002; 21(17):2613-22. DOI: 10.1038/sj.onc.1205353. View

Li Y, Wang Z, Kong D, Li R, Sarkar S, Sarkar F . Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem. 2008; 283(41):27707-27716. PMC: 2562074. DOI: 10.1074/jbc.M802759200. View

Hoffman W, Biade S, Zilfou J, Chen J, Murphy M . Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem. 2001; 277(5):3247-57. DOI: 10.1074/jbc.M106643200. View

Ghosh J, Dohi T, Kang B, Altieri D . Hsp60 regulation of tumor cell apoptosis. J Biol Chem. 2007; 283(8):5188-94. DOI: 10.1074/jbc.M705904200. View

10.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

11.

Calnan D, Brunet A . The FoxO code. Oncogene. 2008; 27(16):2276-88. DOI: 10.1038/onc.2008.21. View

12.

Accili D, Arden K . FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004; 117(4):421-6. DOI: 10.1016/s0092-8674(04)00452-0. View

13.

Ki D, Jeung H, Park C, Kang S, Lee G, Lee W . Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer. 2007; 121(9):2005-2012. DOI: 10.1002/ijc.22975. View

14.

Wang R, Zheng Y, Kim H, Xu X, Cao L, Luhasen T . Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell. 2008; 32(1):11-20. PMC: 2577018. DOI: 10.1016/j.molcel.2008.09.011. View

15.

Manning B, Cantley L . AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. PMC: 2756685. DOI: 10.1016/j.cell.2007.06.009. View

16.

Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J . Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 2003; 4(3):209-21. DOI: 10.1016/s1535-6108(03)00215-0. View

17.

Li A, Piluso L, Cai X, Wei G, Sellers W, Liu X . Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell. 2006; 23(4):575-87. DOI: 10.1016/j.molcel.2006.06.028. View

18.

Zhang T, Otevrel T, Gao Z, Ehrlich S, Fields J, Boman B . Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 2001; 61(24):8664-7. View

19.

Sun L, Hui A, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S . Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 2006; 9(4):287-300. DOI: 10.1016/j.ccr.2006.03.003. View

20.

Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu X . Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res. 2008; 68(9):3152-60. DOI: 10.1158/0008-5472.CAN-07-5348. View